Volume: 4 Issue: 3
Year: 2016, Page: 39-41,
Introduction: Zinc is an essential trace element that is essential for overall growth and development and for the proper functioning of the immune system. Deficiency of zinc can enhance the expression of certain proteins known as angiotensin II that constrict the blood vessels in kidneys and further aggravate the condition of individuals with obstructive kidney disease. Chronic kidney disease (CKD) is one of the leading cause of morbidity and mortality worldwide. Incidence of CKD is rising which is likely to pose major problem for both health care and economy in India. Dialysis is a form of renal replacement therapy for severe kidney failure.
Aims and Study: The Present study is aimed to evaluate the role of zinc and renal parameters predicting CKD in patients undergoing hemodialysis.
Material and Methods:A group of 25 normal healthy subjects (controls-A), 25 CKD patients on hemodialysis (test group -B) were enrolled in the study. Zinc, Urea, Creatinine and serum albumin levels were estimated in the sample collected from normal and CKD-HD subjects.paired student’t’test was applied to calculate ‘p’value using graphad calculator.
Results: : The results of two groups were expressed as Mean±SD. The values of zinc and albumin were significantly decreased in CKD-HD group compared with that of controls. ‘P’ value is 0.0001 which was considered as extremely statistically significant.
Conclusion: This study found that decreased zinc can be used as an indicator for severe damage of kidney in hemodialysis.
Keywords: Chronic kidney disease, End stage renal disease, Hypozincemia, Hemodialysis
1) Karl skorecki, Jacob green, and Barry M. Brenner. In: Chronic Renal Failure. Harrison's Principles and Practice of Internal Medicine, 17thedition, Mcgraw–Hill medical publishing Division, volume II, page no. 1653-54.
2) Ajay k singh, youssef MK farag, Bharathi mittal, Epidemioolgy and risk factors of chronic kidney disease in india, 2013.J of Evolution of Med and Dent Sci/Eissn2278-4802,Pissn-2278-4748/vol.4/Issue84/oct19,2015, Page no 14721.
3) M. Sathishbabu, S .Suresh, A study on correlation of serum prealbumin with other biochemical parameters of malnutrition in hemodialysis patient, Int J Biol Med Res. 2012; 3(1): 1410-1412.
4) Suresh chandra dash and Sanjay KA. Incidence of Chronic Kidney disease in India. Nephro Dialysis transplantation 2006; 21(1): 232 - 233.
5) Klotz LO,Kroncke KD, Buchczyk DP, et al. Role of copper, zinc, selenium and tellurium in the cellular defense against oxidative and nitrosative stress. J Nutr. 2003;133:1448- 1451.
6) Jern, N.A., VanBeber, A.D., Gorman, M.A., Weber, C.G., Liepa, G.U. and Cochran, C.C. The Effects of Zinc Supplementation on Serum Zinc Concentration and Protein Catabolic Rate in Hemodialysis Patients. Journal of Rental Nutrition. 2000;10:148-153.
7) Veighey, K., Booth, J. and Davenport, A. Does the Choice of Phosphate Binder Affect Trace Element Levels in Chronic Kidney Disease Patients Treated by Regular Haemodialysis? Nephrology Dialysis Transplantation. 2011;26:1006- 1010.
8) Ribeiro, R.C., Sales, V.S., Neves, F.A.R., Draibe, S. and Brandao-Neto, J. (2004) Effects of Zinc on Cell-Mediated Immunity in Chronic Hemodialysis Patients. Biological Trace Element Research, 98, 209-218.
9) Krachler M, Scharfetter H, Wirnsberger GH. Kinetics of the metal cations magnesium, calcium, copper, zinc, strontium, barium, and lead in chronic hemodialysis patients. Clin Nephrol. 2000;54:35–44.
10) Vanholder R, Cornelis R, Dhondt A, Lameire N. The role of trace elements in uraemic toxicity. Nephrol Dial Transplant. 2002;17:2–8.
11) Neiva TJ, Benedetti AL, Tanaka SM, Santos JI, D'Amico EA. Determination of serum aluminum, platelet aggregation and lipid peroxidation in hemodialyzed patients. Braz J Med Biol Res. 2002;35:345–350.
12) Kalantar-Zadeh K, Kopple JD. Trace elements and vitamins in maintenance dialysis patients. Adv Ren Replace Ther. 2003;10:170–182.
13) Richard MJ, Arnaud J, Jurkovitz C, Hachache T, Meftahi H, Laporte F, et al. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron.1991;57:10–15.
14) Krachler M, Wirnsberger G, Irgolic KJ. Trace element status of hemodialyzed patients.Biol Trace Elem Res. 1997;58:209–221.
15) Akita Abe yiamabhita.s.,clin chem. 1989;35(4): 552-554.
16) Weis W.A klin, wsehr. 1965;43:273.
17) Stenvinkal p: The role of inflammation in the anemia of end stage renal disease, Nephrol Dial Transplant 16(soppl 7): 36-40 2001.
18) Batel, H, creatinine by modified Jaffe’s test. Clin . chem.. Acta 1972; 37:193.
19) Shrimpton R, Gross R, Hill I, Young M: Zinc deficiency: what are the most appropriate interventions? BMJ 2005, 330:347-349.
20) Prasad AS: Zinc in growth and development and spectrum of human zinc deficiency. J Am Coll Nutr 1988, 7:377-384.
21) Rink L, Gabriel P: Zinc and the immune system. Proc Nutr Soc 2000, 59:541-552
22) Shankar AH, Prasad AS: Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr 1998, 68(2):447S-463S.
23) Collins AJ, Kasiske B, Herzog C, Chavers B, Foley R, Gilbertson D, Grimm R, Liu J, Louis T, Manning W, Matas A, McBean M, Murray A, St Peter W, Xue J, Fan Q, Guo H, Li S, Roberts T, Snyder J, Solid C, Wang C, Weinhandl E, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, et al.: Excerpts from the United States Renal Data System 2004 annual data report: atlas of endstage renal disease in the United States. Am J Kidney Dis 2005, 45(1):A5-7.
24) Oliver MJ, Rothwell DM, Fung K, Hux JE, Lok CE: Late creation of vascular access for hemodialysis and increased risk of sepsis. J Am Soc Nephrol 2004; 15:1936-1942.
25) Allon M: Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis 2004, 44:779-791.
26) Mokrzycki MH, Zhang M, Cohen H, Golestaneh L, Laut JM, Rosenberg SO: Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality. Nephrol Dial Transplant 2006, 21:1024-1031.
27) O'Seaghdha CM, Foley RN: Septicemia, access, cardiovascular disease, and death in dialysis patients. Perit Dial Int 2005; 25: 534-540.
28) Ishani A, Collins AJ, Herzog CA, Foley RN: Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int 2005; 68:311-318.
29) Mafra D, Cuppari L, Cozzolino SM Iron and zinc status of patients with chronic renal failure who are not on dialysis. J Ren Nutr. 2002;12:38–41.
30) Bozalioglu S, Ozkan Y, Turan M, Simsek B. Prevalence of zinc deficiency and immune response in short-term hemodialysis. J Trace Elem Med Biol.2005;18:243–249.
31) Esfahani ST, Hamidian MR, Madani A et al . Serum zinc and copper levels in children with chronic renal failure. Pediatr Nephrol.2006;21:1153–1156.
32) Hsieh YY, Shen WS, Lee LY et al. Long-term changes in trace elements in patients undergoing chronic hemodialysis. Biol Trace Elem Res.2006; 109:115–121.
33) Kiziltas H, Ekin S, Erkoc R . Trace element status of chronic renal patients undergoing hemodialysis. Biol Trace Elem Res. 2008;124:103–109.
Sangeeta S, Venu Gopal. Evaluation of Serum Zinc levels In Chronic Kidney Disease patients on Dialysis in North Telangana. Perspectives in medical research 2016;4(3):39-41.